Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: NOVOGENE CORPORATION INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-29 to 2022-12-31
Current total value of award: $54080
Description: THIS FIRM FIXED PRICE PURCHASE ORDER IS AWARDED  FOR GENE EXPRESSION PROFILES (ALIROCUMAB NEUROINFLAMMATION APOPTOSIS) TO  NOVOGENE CORPORATION INC:1271839 IN THE AMOUNT OF $54,080.00  QUOTE# NVUS2022052308